Beemine Laboratories

Beemine Laboratories is a Madrid-based company specializing in the development and distribution of high-quality CBD products and apicultural derivatives, aimed at enhancing wellness through natural ingredients. Founded in 2018, Beemine Laboratories focuses on CBD product development. The company has successfully executed two deals, with its most recent funding round occurring on September 3, 2021, where it raised USD 1. 06 mn in Seed funding from investors including R2 Venture Partners, Faraday Venture Partners, and Keith VC.

The company is led by CEO Telmo Güell. Beemine Lab™ specializes in a broad array of CBD products and apicultural derivatives. Their product line includes CBD oils, creams, balms, and intimate care items, all designed to support various wellness needs. These products are available for purchase online and through pharmacies and herbal shops across several European countries, including Spain, Germany, France, and Italy.

In 2023, Beemine Laboratories reported a revenue of USD 1,934,528. 30 and an EBITDA of USD -77,969. 80 for the same year, reflecting the company's operational performance in the CBD market. Beemine Laboratories plans to leverage its most recent funding of USD 1.

06 mn raised in September 2021 to accelerate its business expansion. The company aims to deepen its market penetration within Spain and introduce its products to new countries. Specific target regions for expansion have not been disclosed, but the company is actively pursuing opportunities to broaden its reach.